PT - JOURNAL ARTICLE AU - Dzieciolowska, Stefka AU - Charest, Hugues AU - Roy, Tonya AU - Fafard, Judith AU - Carazo, Sara AU - Levade, Ines AU - Longtin, Jean AU - Parkes, Leighanne AU - Beaulac, Sylvie Nancy AU - Villeneuve, Jasmin AU - Savard, Patrice AU - Corbeil, Jacques AU - Serres, Gaston De AU - Longtin, Yves TI - Timing and Predictors of Loss of Infectivity among Healthcare Workers with Primary and Recurrent COVID-19: a Prospective Observational Cohort Study AID - 10.1101/2023.06.16.23291449 DP - 2023 Jan 01 TA - medRxiv PG - 2023.06.16.23291449 4099 - http://medrxiv.org/content/early/2023/06/18/2023.06.16.23291449.short 4100 - http://medrxiv.org/content/early/2023/06/18/2023.06.16.23291449.full AB - Background There is a need to understand the duration of infectivity of primary and recurrent COVID-19 and identify predictors of loss of infectivity.Methods Prospective observational cohort study with serial viral culture, rapid antigen detection test (RADT) and RT-PCR on nasopharyngeal specimens of healthcare workers with COVID-19. The primary outcome was viral culture positivity as indicative of infectivity. Predictors of loss of infectivity were determined using multivariate regression model. The performance of the US CDC criteria (fever resolution, symptom improvement and negative RADT) to predict loss of infectivity was also investigated.Results 121 participants (91 female [79.3%]; average age, 40 years) were enrolled. Most (n=107, 88.4%) had received ≥3 SARS-CoV-2 vaccine doses, and 20 (16.5%) had COVID-19 previously. Viral culture positivity decreased from 71.9% (87/121) on day 5 of infection to 18.2% (22/121) on day 10. Participants with recurrent COVID-19 had a lower likelihood of infectivity than those with primary COVID-19 at each follow-up (day 5 OR, 0.14; p<0.001]; day 7 OR, 0.04; p=0.003]) and were all non-infective by day 10 (p=0.02). Independent predictors of infectivity included prior COVID-19 (adjusted OR [aOR] on day 5, 0.005; p=0.003), a RT-PCR Ct value <23 (aOR on day 5, 22.75; p<0.001), but not symptom improvement or RADT result.The CDC criteria would identify 36% (24/67) of all non-infectious individuals on Day 7. However, 17% (5/29) of those meeting all the criteria had a positive viral culture.Conclusions Infectivity of recurrent COVID-19 is shorter than primary infections. Loss of infectivity algorithms could be optimized.Competing Interest StatementY. Longtin reports receiving research support from Summit (Oxford). All other co-authors report no potential conflicts of interest.Funding StatementThis work was funded by the Ministere de la Sante et des Services Sociaux du Quebec. The funding source had no role in the design of the study, execution, analyses, interpretation of data, writing of report or decision to submit the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of the Jewish General Hospital Sir Mortimer B Davis gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript